Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lutrate Depot 22.5 mg in Prostate Cancer
NCT01415960Phase 3Completed
- Sponsor
- GP Pharm
- Start
- Sep 2011
- Primary completion
- May 2013
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of leuprolide in prostate cancer (PCa), sponsored by GP Pharm. Started Sep 2011; status: completed.
02
Drugs
leuprolide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01415960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01415960.